A Decade of JAK Inhibitors: What Have We Learned and What May Be the Future?
Author:
Affiliation:
1. National Institute of Arthritis and Musculoskeletal and Skin Diseases NIH Bethesda Maryland
2. University of Texas Southwestern Medical Center
Publisher
Wiley
Subject
Immunology,Rheumatology,Immunology and Allergy
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1002/art.41906
Reference96 articles.
1. Jak-STAT Pathways and Transcriptional Activation in Response to IFNs and Other Extracellular Signaling Proteins
2. Mutation of Jak3 in a Patient with SCID: Essential Role of Jak3 in Lymphoid Development
3. Prevention of Organ Allograft Rejection by a Specific Janus Kinase 3 Inhibitor
4. A Gain-of-Function Mutation ofJAK2in Myeloproliferative Disorders
5. Human TYK2 deficiency: Mycobacterial and viral infections without hyper-IgE syndrome
Cited by 39 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The JAK-STAT Pathway as a Therapeutic Strategy in Cancer Patients with Immune Checkpoint Inhibitor-Induced Colitis: A Narrative Review;Cancers;2024-01-31
2. Tofacitinib for the treatment of severe rare skin diseases: a narrative review;European Journal of Clinical Pharmacology;2024-01-17
3. Emerging Oral Therapies for the Treatment of Psoriasis: A Review of Pipeline Agents;Pharmaceutics;2024-01-15
4. Ruxolitinib Rescues Multiorgan Clinical Autoimmunity in Patients with APS-1;Journal of Clinical Immunology;2023-12-19
5. Computational 3D Modeling-Based Identification of Inhibitors Targeting Cysteine Covalent Bond Catalysts for JAK3 and CYP3A4 Enzymes in the Treatment of Rheumatoid Arthritis;Molecules;2023-12-19
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3